![\"\"](\"https:\/\/cdn.vanderbilt.edu\/vu-URL\/wp-content\/uploads\/sites\/193\/2026\/03\/05121634\/Jason-Kerkmans-1-200x300.jpg\")
<\/p>\nVISE welcomes Jason Kerkmans, JD, founder of MINDSET Integrated Co, to our Spring Seminar Series.<\/p>\n
<\/p>\n
Date:\u00a0<\/strong>Thursday, March 26, 2026 Title:
\nNEW Location:\u00a0<\/strong>MCN CC-2209
\nTime:\u00a0<\/strong>12:30 pm for lunch,12:40 pm start<\/p>\n
\n<\/strong>From Data to Verdict: How the US Litigation System Advances, Tests, and Distorts Neuroimaging Science
\nAbstract:<\/strong>
Advanced neuroimaging is increasingly entering courtrooms, creating a parallel translational pathway that complements traditional academic publication and the regulatory approval process. Whereas scientific acceptance emphasizes peer review and replication, and regulatory clearance through the U.S. The Food and Drug Administration focuses on population-level safety and efficacy, legal admissibility centers on methodological reliability and individualized application. This talk examines how litigation functions as a real-world validation ecosystem for neuroimaging data analysis. On the translational side, legal cases fund comprehensive evaluations that are often independent of clinical reimbursement constraints. This exposes advanced analytic tools to patients who might not otherwise access them and subjects them to varying levels of transparency through adversarial scrutiny. The legal process also introduces structured bias, strategic challenges, and the risk of misinterpretation under high-stakes conditions. By analyzing how evidence operates across low-value personal injury claims to high-value medical malpractice litigation, this presentation illustrates how legal deployment can refine documentation standards, improve reproducibility, and expose gaps and misuse of regulatory cleared processes. Ultimately, engaging thoughtfully with litigation environments can advance the development of robust, interpretable, and patient-centered neuroimaging algorithms that might otherwise take decades to reach the general population, while also acknowledging the structural risks inherent in adversarial systems.<\/p>\n